ArticleBMJ open2018

Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV).

Antony J Mersiades et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.